2021
Neurotherapeutics

April 27-29, 2021 – Virtual Event

CEO Scott Shandler will be presenting at the Neuroimmunology Drug Development Summit

Neurotherapeutics

January 26-28, 2021 – Virtual Event

CEO Scott Shandler will be presenting at the Longevity Therapeutics Conference 

2020
Neurotherapeutics

September 21 – 24, 2020 – Virtual Event

Longevity Biotech will be attending the Biotech In Europe Forum (BEF)

Neurotherapeutics

July 15, 2020 – Virtual Event

CEO Scott Shandler will be presenting at the Biomarkers for Alzheimer’s Disease Summit

Neurotherapeutics

January 12 – 16, 2020 – San Francisco

Longevity Biotech will be attending the JP Morgan Healthcare conference.   Contact us to schedule a Business Development meeting.

2019
Neurotherapeutics

January 6 – 10, 2019 – San Francisco

Longevity Biotech will be attending the JP Morgan Healthcare conference.   Contact us to schedule a Business Development meeting.

2018
Neurotherapeutics

January 8-11, 2018 – San Francisco, CA

Longevity Biotech will be attending the RESI Healthcare conference. Contact us to schedule a Business Development meeting.

2017
Neurotherapeutics

October 30, 2017 – New York, NY

Longevity Biotech will be attending the annual Michael J. Fox Foundation Parkinson’s Disease meeting in NYC.
Please contact us to schedule a one-on-one meeting.

MS Society

October 27, 2017 – Philadelphia, PA

Longevity Biotech is pleased to announce funding support from the National Multiple Sclerosis Society to our evaluate lead candidate, LBT-3627, as a potential treatment for MS.

Neurotherapeutics

October 19, 2017 – San Francisco, CA

Longevity Biotech will attend the Breakout Labs Annual Unboxing Event, please contact us to schedule a Business Development meeting.

Neurotherapeutics

April 6, 2017 – New York, NY

Longevity Biotech will attend the Breakout Labs East Coast Event, please contact us to schedule a Business Development meeting.

Neurotherapeutics

February 10, 2017 – Philadelphia, PA

The Hybridtide platform technology is highlighted in an Angewandte Chemie publication: New Modalities for Challenging Targets in Drug Discovery.

Neurotherapeutics

February 7, 2017 – Philadelphia, PA

Longevity Biotech and University of Nebraska Medical center announce follow-on funding for the development of LBT-3627 as a novel therapeutic strategy for Parkinson’s disease.

Neurotherapeutics

January 10, 2017 – San Francisco, CA

Longevity Biotech is attending the RESI 2017 conference, please contact us to schedule a Business Development meeting.

2016
Neurotherapeutics

November 13-16, 2016 – New York, NY
Longevity Biotech is attending the Partnering For Cures conference in NYC. Please contact us to schedule a Business Development meeting.

Neurotherapeutics

October 20, 2016 – San Francisco, CA
Longevity Biotech is attending the Breakout Labs Unboxing event. Please contact us to schedule a Business Development meeting.

Neurotherapeutics

June 21, 2016 – Omaha, NE & Philadelphia, PA
UNMC & Longevity Biotech publish novel neurodegenerative diagnostic imaging approach for Parkinson’s disease using LBT-3627.

Manganese-Enhanced Magnetic Resonance Imaging for Detection of Vasoactive Intestinal Peptide Receptor 2 Agonist Therapy in a Model of Parkinson’s Disease

June 6-9, 2016 – San Francisco, CA
Longevity Biotech will participate as part of the Innovation zone

June 6-7, 2016 – Atlanta, GA
Longevity Biotech will attend the NSF Phase II SBIR Conference.

April 6-7, 2016 – Boston, MA
Longevity Biotech Presents at NIO Neurotech Investing and Partnering conference

February 5th, 2016 – Philadelphia, PA
Longevity Biotech featured in Philadelphia Business Journal

2015

June 15-18th, 2015 – Philadelphia PRESENTATION Tuesday June 16th @ 3:15pm. Theater 3, “Doctor Nucleus”
Longevity Biotech will be participating at this year’s international BIO conference. Please contact us to schedule 1-on-1 meetings.

2014

December 13th-14th, 2014 – Verbier, Switzerland
NetScientific hosts portfolio conference in Verbier

September 22-24th, 2014 – Boulder, Colorado
Longevity Biotech to attend Boulder Peptide Symposium

July 23rd, 2014 – San Francisco, California
NetScientific announces investment in Longevity Biotech

June 25th, 2014 – San Diego, California
CEO Scott Shandler Interviewed at BIO

June 23rd – June 26th, 2014 – San Diego, California
Longevity Biotech Selected to present at BIO 2014 International Convention

February 21, 2014 – Philadelphia, Pennsylvania
Longevity’s Hybridtides not just ‘me-too’ peptides

2013
2012

November 13-14th, 2012 – Madison, Wisconsin
Wisconsin Investors Forum

April 17, 2012 – San Francisco, California
Tech visionary Thiel sets out to spark a biotech revolution

2011